“By just making the reagent readily available, it promoted more people to work on an essential issue and advance the field much faster,” Levine says.While a citation is appreciated, there are no authorship requirements, no partnerships expected … and no fees.Bradners option to make JQ1 available for totally free runs counter to the method science is typically done, where experimentalists buy their reagents from business entities and closely safeguard the intellectual home that results from their research study. While easily sharing reagents is not without its risks for the researchers who manage these jobs, those who spoke to The Scientist say that the problems are surpassed by the contributions they make to their own fields– as well as to the fields of their collaborators– by sharing more freely. Some recipients of scientist-made reagents mention this personal connection with the reagent designer as one of the biggest pluses of working with other researchers instead of commercial suppliers. Matthew Bogyo, a chemical biologist at Stanford Medicine, informs The Scientist in an e-mail that “we have actually offered companies a supply … for a set rate so that they can package and sell it for a profit,” adding that “this is simply due to the fact that the major expense to my laboratory to make the reagent readily available is the effort of preparing a sample, product packaging it and sending it out. While he doesnt manufacture reagents himself, Bisson says that he is updating his website to make his pressures lists, methods, and protocols– even those he has yet to release– freely available.
“By simply making the reagent readily available, it promoted more people to work on an important issue and advance the field much faster,” Levine says.While a citation is appreciated, there are no authorship requirements, no collaborations expected … and no fees.Bradners choice to make JQ1 readily available for free runs counter to the method science is usually done, where experimentalists purchase their reagents from industrial entities and carefully guard the intellectual home that results from their research study. Some recipients of scientist-made reagents cite this personal connection with the reagent designer as one of the greatest pluses of working with other researchers rather of commercial suppliers. Matthew Bogyo, a chemical biologist at Stanford Medicine, informs The Scientist in an e-mail that “we have offered companies a supply … for a set cost so that they can package and offer it for a revenue,” including that “this is merely since the significant expense to my laboratory to make the reagent offered is the effort of preparing a sample, product packaging it and sending it out.
